Sunday July 05 2009 | Biotechnology feed | All feeds
|
|
Sunday July 05 2009 | Biotechnology feed | All feeds
|
|
|
ST. LOUIS, MO,
and Taufkirchen, Germany, 9th November
2005 - The
Sigma-Aldrich Corporation's Board of Directors announced today the
appointment of Jai Nagarkatti, 58, (President and Chief Operating Officer)
as President and Chief Executive Officer effective January 1, 2006. He will
succeed Chairman and Chief Executive Officer David Harvey, 66, who will
continue to serve as Chairman of the Company's Board of Directors. Jai
Nagarkatti was also elected today as a member of the Board of Directors.
Speaking on behalf of the Board,
David R. Harvey stated, "Jai Nagarkatti is a very seasoned and knowledgeable
leader who has had a major impact on the success and growth of
Sigma-Aldrich. His experience and insight into our business will serve the
Company well as we continue our focus on Life Science and High Technology."
Jai Nagarkatti noted, "I am
pleased by the vote of confidence that the Board of Directors and David
Harvey have given me and I look forward to the challenge of accelerating the
performance of Sigma-Aldrich and strengthening the Company's position as a
worldwide leader in our research and fine chemical businesses."
The 29-year Sigma-Aldrich career
of Jai Nagarkatti has spanned R&D, production, operations and sales and
marketing. Since August 2004, he has been Chief Operating Officer and
President. Previously he served as the President of the largest research
division and the fine chemicals business.
Jai Nagarkatti, a U.S. citizen,
was born in Hyderabad, India. He obtained his Master's degree in chemistry
at Osmania University in Hyderabad and subsequently a Ph.D. in organic
chemistry at Texas A&M University.
About Sigma-Aldrich:
Sigma-Aldrich (Nasdaq:
SIAL) is a leading Life Science and High Technology
company. Our biochemical and organic chemical products and
kits are used in scientific and genomic research, biotechnology,
pharmaceutical development, the diagnosis of disease and as key components
in pharmaceutical and other high technology manufacturing. We have customers
in life science companies, university and government institutions, hospitals
and in industry. Over one million scientists and technologists use our
products. Sigma-Aldrich operates in 35 countries and has over 6,800
employees providing excellent service worldwide. We are committed to
accelerating Customers' success through leadership in Life
Science, High Technology and Service. For more information
about Sigma-Aldrich, please visit our award-winning web site at
http://www.sigma-aldrich.com.
Media enquiries in Europe
to Northbank Communications:
Marc Egelhofer, Tel: +44 (0)1260 296505 m.egelhofer@northbankcommunications.com
At Sigma-Aldrich:
Kirk A. Richter,
Treasurer of Sigma-Aldrich Corporation,
Tel: +1-314-286-8004 |
|
|
